Last 12 months
Inside the activity.
0 purchase rows · 6 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 2 |
| Aug 2026 | 0 | 3 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| October 09, 2026 Filed Oct 13, 2026 20:08 UTC |
Tardugno Michael HDirector · Executive Chairman of Board
|
GrantCommon Stock | 7,800 | $1.08 | $8,424.00 |
DisclosureSEC source: 0001437749-26-032563 · rdgdoc.xml · nonDerivative · entry 1 Tardugno Michael H · CIK 0001384550 · Director · Executive Chairman of Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,721 F1 · shares: Stock granted in lieu of cash for base salary Read SEC document |
| October 09, 2026 Filed Oct 13, 2026 20:06 UTC |
Lindborg StacyDirector · President and CEO
|
GrantCommon Stock | 2,977 | $1.08 | $3,215.16 |
DisclosureSEC source: 0001437749-26-032562 · rdgdoc.xml · nonDerivative · entry 1 Lindborg Stacy · CIK 0001813667 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 116,174 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| October 09, 2026 Filed Oct 13, 2026 20:05 UTC |
Faller Douglas VincentChief Medical Officer
|
GrantCommon Stock | 1,249 | $1.08 | $1,348.92 |
DisclosureSEC source: 0001437749-26-032560 · rdgdoc.xml · nonDerivative · entry 1 Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 46,927 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| September 25, 2026 Filed Sep 28, 2026 20:31 UTC |
Tardugno Michael HDirector · Executive Chairman of Board
|
GrantCommon Stock | 7,169 | $1.41 | $10,108.29 |
DisclosureSEC source: 0001437749-26-031363 · rdgdoc.xml · nonDerivative · entry 1 Tardugno Michael H · CIK 0001384550 · Director · Executive Chairman of Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,921 F1 · shares: Stock granted in lieu of cash for base salary Read SEC document |
| September 25, 2026 Filed Sep 28, 2026 20:30 UTC |
Lindborg StacyDirector · President and CEO
|
GrantCommon Stock | 6,697 | $1.41 | $9,442.77 |
DisclosureSEC source: 0001437749-26-031362 · rdgdoc.xml · nonDerivative · entry 1 Lindborg Stacy · CIK 0001813667 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,197 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| September 25, 2026 Filed Sep 28, 2026 20:29 UTC |
Faller Douglas VincentChief Medical Officer
|
GrantCommon Stock | 4,390 | $1.41 | $6,189.90 |
DisclosureSEC source: 0001437749-26-031360 · rdgdoc.xml · nonDerivative · entry 1 Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,678 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 16:43 UTC |
Tardugno Michael HDirector · Executive Chairman of Board
|
GrantCommon Stock | 5,824 | $1.47 | $8,561.28 |
DisclosureSEC source: 0001437749-26-030415 · rdgdoc.xml · nonDerivative · entry 1 Tardugno Michael H · CIK 0001384550 · Director · Executive Chairman of Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,699 F1 · shares: Stock granted in lieu of cash for base salary Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 16:42 UTC |
Lindborg StacyDirector · President and CEO
|
GrantCommon Stock | 5,504 | $1.47 | $8,090.88 |
DisclosureSEC source: 0001437749-26-030414 · rdgdoc.xml · nonDerivative · entry 1 Lindborg Stacy · CIK 0001813667 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,580 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| September 11, 2026 Filed Sep 15, 2026 16:41 UTC |
Faller Douglas VincentChief Medical Officer
|
GrantCommon Stock | 4,211 | $1.47 | $6,190.17 |
DisclosureSEC source: 0001437749-26-030413 · rdgdoc.xml · nonDerivative · entry 1 Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,288 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| August 31, 2026 Filed Sep 1, 2026 20:06 UTC |
Eylward SusanGeneral Counsel and Corp Sec
|
SaleCommon Stock | 2,525 | $1.56 | $3,949.86 |
DisclosureSEC source: 0001437749-26-029405 · rdgdoc.xml · nonDerivative · entry 2 Eylward Susan · CIK 0002039135 · General Counsel and Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,896 F2 · price: Reflects a weighted average sale price of $1.5643 per share, at prices ranging from $1.55 to $1.58 per share. The reporting person will provide, upon request by the staff of the Securities and Exchange Commission, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 28, 2026 Filed Sep 1, 2026 20:10 UTC |
Tardugno Michael HDirector · Executive Chairman of Board
|
GrantCommon Stock | 7,371 | $1.60 | $11,793.60 |
DisclosureSEC source: 0001437749-26-029409 · rdgdoc.xml · nonDerivative · entry 1 Tardugno Michael H · CIK 0001384550 · Director · Executive Chairman of Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 89,875 F1 · shares: Stock granted in lieu of cash for base salary Read SEC document |
| August 28, 2026 Filed Sep 1, 2026 20:09 UTC |
Lindborg StacyDirector · President and CEO
|
GrantCommon Stock | 6,822 | $1.60 | $10,915.20 |
DisclosureSEC source: 0001437749-26-029408 · rdgdoc.xml · nonDerivative · entry 1 Lindborg Stacy · CIK 0001813667 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,076 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| August 28, 2026 Filed Sep 1, 2026 20:07 UTC |
Faller Douglas VincentChief Medical Officer
|
GrantCommon Stock | 3,626 | $1.60 | $5,801.60 |
DisclosureSEC source: 0001437749-26-029407 · rdgdoc.xml · nonDerivative · entry 1 Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,077 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| August 28, 2026 Filed Sep 1, 2026 20:06 UTC |
Eylward SusanGeneral Counsel and Corp Sec
|
GrantCommon Stock | 2,525 | $1.60 | $4,040.00 |
DisclosureSEC source: 0001437749-26-029405 · rdgdoc.xml · nonDerivative · entry 1 Eylward Susan · CIK 0002039135 · General Counsel and Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,421 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| August 17, 2026 Filed Aug 17, 2026 20:17 UTC |
Eylward SusanGeneral Counsel and Corp Sec
|
SaleCommon Stock | 2,449 | $1.63 | $3,992.60 |
DisclosureSEC source: 0001437749-26-028184 · rdgdoc.xml · nonDerivative · entry 2 Eylward Susan · CIK 0002039135 · General Counsel and Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,896 F2 · price: Reflects a weighted average sale price of $1.6303 per share, at prices ranging from $1.61 to $1.655 per share. The reporting person will provide, upon request by the staff of the Securities and Exchange Commission, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price. Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 20:22 UTC |
Lindborg StacyDirector · President and CEO
|
GrantCommon Stock | 6,615 | $1.65 | $10,914.75 |
DisclosureSEC source: 0001437749-26-028187 · rdgdoc.xml · nonDerivative · entry 1 Lindborg Stacy · CIK 0001813667 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 93,254 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 20:21 UTC |
Faller Douglas VincentChief Medical Officer
|
GrantCommon Stock | 3,516 | $1.65 | $5,801.40 |
DisclosureSEC source: 0001437749-26-028186 · rdgdoc.xml · nonDerivative · entry 1 Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,451 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 20:21 UTC |
Tardugno Michael HDirector · Executive Chairman of Board
|
GrantCommon Stock | 7,147 | $1.65 | $11,792.55 |
DisclosureSEC source: 0001437749-26-028185 · rdgdoc.xml · nonDerivative · entry 1 Tardugno Michael H · CIK 0001384550 · Director · Executive Chairman of Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 82,504 F1 · shares: Stock granted in lieu of cash for base salary Read SEC document |
| August 14, 2026 Filed Aug 17, 2026 20:17 UTC |
Eylward SusanGeneral Counsel and Corp Sec
|
GrantCommon Stock | 2,449 | $1.65 | $4,040.85 |
DisclosureSEC source: 0001437749-26-028184 · rdgdoc.xml · nonDerivative · entry 1 Eylward Susan · CIK 0002039135 · General Counsel and Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,345 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| August 03, 2026 Filed Aug 4, 2026 20:13 UTC |
Eylward SusanGeneral Counsel and Corp Sec
|
SaleCommon Stock | 2,541 | $1.57 | $3,976.92 |
DisclosureSEC source: 0001437749-26-025661 · rdgdoc.xml · nonDerivative · entry 2 Eylward Susan · CIK 0002039135 · General Counsel and Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,896 F2 · price: Reflects a weighted average sale price of $1.5651 per share, at prices ranging from $1.56 to $1.575 per share. The reporting person will provide, upon request by the staff of the Securities and Exchange Commission, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:17 UTC |
Pellizzari Christine ADirector
|
GrantCommon Stock | 6,934 | $1.59 | $11,025.06 |
DisclosureSEC source: 0001437749-26-025671 · rdgdoc.xml · nonDerivative · entry 1 Pellizzari Christine A · CIK 0001127430 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,076 F1 · shares: Stock granted in lieu of cash for portion of board fees Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:16 UTC |
Dentzer James EDirector
|
GrantCommon Stock | 6,934 | $1.59 | $11,025.06 |
DisclosureSEC source: 0001437749-26-025667 · rdgdoc.xml · nonDerivative · entry 1 Dentzer James E · CIK 0001400977 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,897 F1 · shares: Stock granted in lieu of cash for portion of board fees Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:14 UTC |
Braun Donald PDirector
|
GrantCommon Stock | 6,180 | $1.59 | $9,826.20 |
DisclosureSEC source: 0001437749-26-025663 · rdgdoc.xml · nonDerivative · entry 1 Braun Donald P · CIK 0001661392 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,499 F1 · shares: Stock granted in lieu of cash for portion of board fees Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:15 UTC |
Fritz Frederick J.Director
|
GrantCommon Stock | 6,934 | $1.59 | $11,025.06 |
DisclosureSEC source: 0001437749-26-025665 · rdgdoc.xml · nonDerivative · entry 1 Fritz Frederick J. · CIK 0001525250 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,031 F1 · shares: Stock granted in lieu of cash for portion of board fees. Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:13 UTC |
Eylward SusanGeneral Counsel and Corp Sec
|
GrantCommon Stock | 2,541 | $1.59 | $4,040.19 |
DisclosureSEC source: 0001437749-26-025661 · rdgdoc.xml · nonDerivative · entry 1 Eylward Susan · CIK 0002039135 · General Counsel and Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,437 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:12 UTC |
Tardugno Michael HDirector · Executive Chairman of Board
|
GrantCommon Stock | 6,358 | $1.59 | $10,109.22 |
DisclosureSEC source: 0001437749-26-025660 · rdgdoc.xml · nonDerivative · entry 1 Tardugno Michael H · CIK 0001384550 · Director · Executive Chairman of Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,357 F1 · shares: Stock granted in lieu of cash for base salary Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:11 UTC |
Faller Douglas VincentChief Medical Officer
|
GrantCommon Stock | 3,649 | $1.59 | $5,801.91 |
DisclosureSEC source: 0001437749-26-025658 · rdgdoc.xml · nonDerivative · entry 1 Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,935 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| July 31, 2026 Filed Aug 4, 2026 20:10 UTC |
Lindborg StacyDirector · President and CEO
|
GrantCommon Stock | 5,010 | $1.59 | $7,965.90 |
DisclosureSEC source: 0001437749-26-025655 · rdgdoc.xml · nonDerivative · entry 1 Lindborg Stacy · CIK 0001813667 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,639 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| July 20, 2026 Filed Jul 21, 2026 20:15 UTC |
Eylward SusanGeneral Counsel and Corp Sec
|
SaleCommon Stock | 2,150 | $1.78 | $3,830.44 |
DisclosureSEC source: 0001437749-26-023948 · rdgdoc.xml · nonDerivative · entry 2 Eylward Susan · CIK 0002039135 · General Counsel and Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,896 F2 · price: Reflects a weighted average sale price of $1.7816 per share, at prices ranging from $1.76 to $1.79 per share. The reporting person will provide, upon request by the staff of the Securities and Exchange Commission, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price. Read SEC document |
| July 17, 2026 Filed Jul 21, 2026 20:17 UTC |
Tardugno Michael HDirector · Executive Chairman of Board
|
GrantCommon Stock | 4,603 | $1.83 | $8,423.49 |
DisclosureSEC source: 0001437749-26-023949 · rdgdoc.xml · nonDerivative · entry 1 Tardugno Michael H · CIK 0001384550 · Director · Executive Chairman of Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 68,999 F1 · shares: Stock granted in lieu of cash for base salary Read SEC document |
| July 17, 2026 Filed Jul 21, 2026 20:15 UTC |
Eylward SusanGeneral Counsel and Corp Sec
|
GrantCommon Stock | 2,150 | $1.83 | $3,934.50 |
DisclosureSEC source: 0001437749-26-023948 · rdgdoc.xml · nonDerivative · entry 1 Eylward Susan · CIK 0002039135 · General Counsel and Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,046 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| July 17, 2026 Filed Jul 21, 2026 20:15 UTC |
Faller Douglas VincentChief Medical Officer
|
GrantCommon Stock | 3,082 | $1.83 | $5,640.06 |
DisclosureSEC source: 0001437749-26-023947 · rdgdoc.xml · nonDerivative · entry 1 Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,286 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| July 17, 2026 Filed Jul 21, 2026 20:14 UTC |
Lindborg StacyDirector · President and CEO
|
GrantCommon Stock | 4,907 | $1.83 | $8,979.81 |
DisclosureSEC source: 0001437749-26-023946 · rdgdoc.xml · nonDerivative · entry 1 Lindborg Stacy · CIK 0001813667 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 81,629 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| July 06, 2026 Filed Jul 7, 2026 20:58 UTC |
Eylward SusanGeneral Counsel and Corp Sec
|
SaleCommon Stock | 920 | $1.88 | $1,729.60 |
DisclosureSEC source: 0001437749-26-022944 · rdgdoc.xml · nonDerivative · entry 2 Eylward Susan · CIK 0002039135 · General Counsel and Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,896 Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 21:05 UTC |
Tardugno Michael HDirector · Executive Chairman of Board
|
GrantCommon Stock | 4,410 | $1.91 | $8,423.10 |
DisclosureSEC source: 0001437749-26-022948 · rdgdoc.xml · nonDerivative · entry 1 Tardugno Michael H · CIK 0001384550 · Director · Executive Chairman of Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 64,396 F1 · shares: Stock granted in lieu of cash for base salary Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 20:58 UTC |
Eylward SusanGeneral Counsel and Corp Sec
|
GrantCommon Stock | 920 | $1.91 | $1,757.20 |
DisclosureSEC source: 0001437749-26-022944 · rdgdoc.xml · nonDerivative · entry 1 Eylward Susan · CIK 0002039135 · General Counsel and Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,816 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 20:56 UTC |
Faller Douglas VincentChief Medical Officer
|
GrantCommon Stock | 1,308 | $1.91 | $2,498.28 |
DisclosureSEC source: 0001437749-26-022943 · rdgdoc.xml · nonDerivative · entry 1 Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,204 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| July 02, 2026 Filed Jul 7, 2026 20:56 UTC |
Lindborg StacyDirector · President and CEO
|
GrantCommon Stock | 2,534 | $1.91 | $4,839.94 |
DisclosureSEC source: 0001437749-26-022941 · rdgdoc.xml · nonDerivative · entry 1 Lindborg Stacy · CIK 0001813667 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 76,722 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| June 29, 2026 Filed Jun 29, 2026 20:34 UTC |
Eylward SusanGeneral Counsel and Corp Sec
|
SaleCommon Stock | 11,800 | $1.75 | $20,673.60 |
DisclosureSEC source: 0001437749-26-022008 · rdgdoc.xml · nonDerivative · entry 2 Eylward Susan · CIK 0002039135 · General Counsel and Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,896 F2 · price: Reflects a weighted average sale price of $1.752 per share, at prices ranging from $1.73 to $1.80 per share. The reporting person will provide, upon request by the staff of the Securities and Exchange Commission, the Company, or a security holder of the Company, full information regarding the number of shares sold at each separate price. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:35 UTC |
Faller Douglas VincentChief Medical Officer
|
GrantCommon Stock | 21,896 | $1.72 | $37,661.12 |
DisclosureSEC source: 0001437749-26-022009 · rdgdoc.xml · nonDerivative · entry 1 Faller Douglas Vincent · CIK 0002056033 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,896 F1 · shares: Stock granted in lieu of cash for 50% of 2025 annual cash bonus Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:34 UTC |
Eylward SusanGeneral Counsel and Corp Sec
|
GrantCommon Stock | 14,696 | $1.72 | $25,277.12 |
DisclosureSEC source: 0001437749-26-022008 · rdgdoc.xml · nonDerivative · entry 1 Eylward Susan · CIK 0002039135 · General Counsel and Corp Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,696 F1 · shares: Stock granted in lieu of cash for 50% of 2025 annual cash bonus Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:22 UTC |
Tardugno Michael HDirector · Executive Chairman of Board
|
GrantCommon Stock | 42,519 | $1.72 | $73,132.68 |
DisclosureSEC source: 0001437749-26-022003 · rdgdoc.xml · nonDerivative · entry 1 Tardugno Michael H · CIK 0001384550 · Director · Executive Chairman of Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,986 F1 · shares: Stock granted in lieu of cash for 50% of 2025 annual cash bonus Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 20:21 UTC |
Lindborg StacyDirector · President and CEO
|
GrantCommon Stock | 67,150 | $1.72 | $115,498.00 |
DisclosureSEC source: 0001437749-26-022001 · rdgdoc.xml · nonDerivative · entry 1 Lindborg Stacy · CIK 0001813667 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,188 F1 · shares: Stock granted in lieu of cash for 50% of 2025 annual cash bonus Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 23:59 UTC |
Tardugno Michael HDirector · Executive Chairman of Board
|
GrantCommon Stock | 4,629 | $1.82 | $8,424.78 |
DisclosureSEC source: 0001437749-26-021484 · rdgdoc.xml · nonDerivative · entry 1 Tardugno Michael H · CIK 0001384550 · Director · Executive Chairman of Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,467 F1 · shares: Stock granted in lieu of cash for base salary Read SEC document |
| June 18, 2026 Filed Jun 23, 2026 20:17 UTC |
Lindborg StacyDirector · President and CEO
|
GrantCommon Stock | 1,803 | $1.82 | $3,281.46 |
DisclosureSEC source: 0001437749-26-021444 · rdgdoc.xml · nonDerivative · entry 1 Lindborg Stacy · CIK 0001813667 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,038 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 21:15 UTC |
Tardugno Michael HDirector · Executive Chairman of Board
|
GrantCommon Stock | 4,089 | $2.06 | $8,423.34 |
DisclosureSEC source: 0001437749-26-020037 · rdgdoc.xml · nonDerivative · entry 1 Tardugno Michael H · CIK 0001384550 · Director · Executive Chairman of Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,838 F1 · shares: Stock granted in lieu of cash for base salary Read SEC document |
| June 05, 2026 Filed Jun 9, 2026 20:14 UTC |
Lindborg StacyDirector · President and CEO
|
GrantCommon Stock | 1,593 | $2.06 | $3,281.58 |
DisclosureSEC source: 0001437749-26-019994 · rdgdoc.xml · nonDerivative · entry 1 Lindborg Stacy · CIK 0001813667 · Director · President and CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,235 F1 · shares: Stock granted in lieu of cash for portion of base salary Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:22 UTC |
Tardugno Michael HDirector · Executive Chairman of Board
|
GrantCommon Stock | 3,484 | $2.20 | $7,664.80 |
DisclosureSEC source: 0001437749-26-018566 · rdgdoc.xml · nonDerivative · entry 1 Tardugno Michael H · CIK 0001384550 · Director · Executive Chairman of Board 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,749 F1 · shares: Stock granted in lieu of cash for base salary Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:13 UTC |
Pellizzari Christine ADirector
|
GrantCommon Stock | 5,557 | $2.20 | $12,225.40 |
DisclosureSEC source: 0001437749-26-018550 · rdgdoc.xml · nonDerivative · entry 1 Pellizzari Christine A · CIK 0001127430 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,142 F1 · shares: Stock granted in lieu of cash for portion of board fees Read SEC document |
| May 22, 2026 Filed May 27, 2026 20:13 UTC |
Dentzer James EDirector
|
GrantCommon Stock | 11,148 | $2.20 | $24,525.60 |
DisclosureSEC source: 0001437749-26-018549 · rdgdoc.xml · nonDerivative · entry 1 Dentzer James E · CIK 0001400977 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,963 F1 · shares: Stock granted in lieu of cash for portion of board fees Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.